Tackling aging with the power of a global community

VitaDAO is a community-owned collective dedicated to funding and advancing exceptional longevity science research that will help people live longer, healthier lives. With your support we can turn the tide on age related disease.

Support for researchers

Connect with an active community of longevity scientists and get funding for your work.

Work With Us

Join the community

Contribute skills to help us advance longevity science. VitaDAO is owned and built by our community.

Contribute to the DAO

The VITA token

Everything you need to know about the governance token that powers our community

Discover VITA

Read The VitaDAO Longevity
Briefing Primer

Dive into the world of longevity research and discover the unlocked potential to revolutionize healthcare, improve human quality of life and address the challenges faced by an aging population.

Start reading now

$4m+

Funding Deployed

20

Research Projects Funded

$6M+

Liquid Funds

9000+

Community Members

19 Projects funded with $4 million
See all projects

IPNFTs & equity deals

Contribute to treasury
Equity

Humanity

Humanity is a quantified-self app that connects wearables and activity apps to monitor digital biomarkers. The app generates a proprietary aging score, helping users understand activities that slow down or reverse their aging rate. The company uses behavior modification tools and develops biomarkers to guide users toward better healthspan interventions.

$ 50,000
raised
View Project
IP-NFT

Matrix Bio

VitaDAO and the Gorbunova Lab are launching Matrix Bio, a cutting-edge research venture leveraging the anti-cancer and pro-longevity effects of high molecular weight hyaluronic acid from naked mole rat to human.

$ 300,000
raised
View Project
Equity

BE Therapeutics - Brain Tissue Replacement

The neocortex, the part that underlies our highest cognitive functions and self-identity, can be replaced by progressively replacing tissue areas over time without significant disruption in function or self-identity. This offers the possibility of age reversal for the neocortex through progressive tissue replacement.

$ 100,000
raised
View Project
Equity

ExcepGen Inc - RNA therapeutics for longevity

ExcepGen uses its RNAx platform to develop advanced vaccines that address viral infections linked to premature aging and shortened lifespan. The platform improves RNA cargo's effectiveness, promoting significant protein production for enhanced protection.

$ 100,000
raised
View Project

Non-profit initiatives

Make a donation

Support of Clinical Trial - The Effect of Regular Exercise & Intermittent Rapamycin Dosing

Grant

This clinical trial aims to investigate whether periods of time where the mechanistic target of Rapamycin (mTOR) pathway is activated via exercise, combined with alternate periods of time where mTOR is inhibited using Sirolimus (Rapamycin), will result in greater muscle performance in older adults compared with just exercise alone.

$ 50,000
raised
View Project

Discover more longevity science projects funded by VitaDAO

INTRODUCING

An overlay journal curating the world’s most promising longevity research.

Our Partners

Get involved today - support the science of tomorrow.

For Researchers

We support researchers at every stage of their career and provide funding to qualifying projects.

For Contributors

Help us build the world’s leading longevity DAO and get rewarded for your skills.

For Supporters

Beat age related disease by empowering the research bringing new therapeutics to market.

The VitaDAO Genesis hoodie is now available

Order now